Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Tokyo VD who wrote (4710)	7/8/1998 8:36:00 PM
From: Hank	Respond to of 7041

Pfizer's sales literature compares Viagra to Vasoscam because Vasoscam is Viagra's closest POTENTIAL competition (read- NDA expected). Pfizer is just covering their butts. It doesn't mean they have an opinion about Vasoscam's potential for FDA approval. They teach that sort of thing in business school don't they?

To: Tokyo VD who wrote (4710)	7/8/1998 9:32:00 PM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

LOL! I don't think that Claud Baruch's information is likely to be quite accurate. It's unlikely that Pfizer said "Vasomax is a real drug." But let's see if we can be provided with the reference. More or less like Myron's saying: "ZONA is making money in Mexico" and never provided figures or documentation of any kind. Linda